Search
for
Sort by
Research 781–810 of 1000+
- Saw palmetto and finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome
- SRD5A2 and emerging therapies in androgen-driven disorders
- Pathophysiology, conventional treatments, and evidence-based herbal remedies of hair loss with a systematic review of controlled clinical trials
- Intracrine androgen biosynthesis, metabolism and action revisited
- Management of Hirsutism
- Androgenetic alopecia
- Cytochrome P450: A Target for Drug Development for Skin Diseases
- The antiinflammatory effects of Xuefu Zhuyu decoction on C3H/HeJ mice with alopecia areata
- Pharmacology of Natural Volatiles and Essential Oils in Food, Therapy, and Disease Prophylaxis
- Telomere Dynamics and Telomerase in the Biology of Hair Follicles and their Stem Cells as a Model for Aging Research
- Simultaneous Target-Mediated Drug Disposition-Pharmacodynamic (TMDD-PD) Modeling of Finasteride and Dutasteride: Impact of Target Binding and Turnover on Non-linear Pharmacokinetics
- Female Pattern Hair Loss
- Hyperandrogenism and Polycystic Ovary Syndrome in Women with Type 1 Diabetes Mellitus
- Type 1 interferon signature in the scalp lesions of alopecia areata
- Human type 3 5α-reductase is expressed in peripheral tissues at higher levels than types 1 and 2 and its activity is potently inhibited by finasteride and dutasteride
- Hair corticosterone measurement in mouse models of type 1 and type 2 diabetes mellitus
- Pharmacokinetic parameters and mechanisms of inhibition of rat type 1 and 2 steroid 5α-reductases: determinants for different in vivo activities of GI198745 and finasteride in the rat 3 3Abbreviations: r5AR1, rat 5α-reductase 1; r5AR2, rat 5α-reductase 2; and DHT, dihydrotestosterone.
- Insulin Promotes Corneal Nerve Repair and Wound Healing in Type 1 Diabetic Mice by Enhancing Wnt/β-Catenin Signaling
- Pernicious anemia in a patient with Type 1 diabetes mellitus and alopecia areata universalis
- Type 1 Diabetes Mellitus and Autoimmune Diseases: A Critical Review of the Association and the Application of Personalized Medicine
- Type 1 interferon signature and cytotoxic T lymphocyte activation targeted against sweat ducts in inflammatory acquired idiopathic generalized anhidrosis
- Effect of metformin on clinical and biochemical hyperandrogenism in adolescent girls with type 1 diabetes
- Effect of MK-386, a novel inhibitor of type 1 5 alpha-reductase, alone and in combination with finasteride, on serum dihydrotestosterone concentrations in men.
- Expression of type 1 5α-reductase and metabolism of testosterone in reconstructed human epidermis (SkinEthic®): a new model for screening skin-targeted androgen modulators
- Proliferative diabetic retinopathy as onset of type 1 diabetes
- Co-occurrence of monilethrix and Type 1 diabetes mellitus
- Vitiligo and Alopecia Areata as Early Signs Preceding Type 1 Diabetes Mellitus
- Lipoprotein and inflammatory glycoprotein profiles in women with polycystic ovary syndrome alone or in association with type 1 diabetes
- Androgen excess disorders remain undiagnosed in one of every four premenopausal women with Type 1 diabetes
- A RARE CASE OF SIMULATANEOUS DEVELOPMENT OF ALOPECIA AREATA UNIVERSALIS AND TYPE 1 DIABETES MELLITUS